Cellen Therapeutics is an independent, UK-based company working with industry and research partners to ensure patients receive products compliant with EU GACP, EU GMP and EU GDP standards. Cellen is also a founding member of Project Twenty21.
Cellen Therapeutics was founded by NHS specialists with a mission to improve the health and wellbeing of people living with chronic conditions, by improving access to pharmaceutical-grade Medical Cannabis.